EFOMS
What it found
We found no results in the registry or in papers.
This trial finished 14 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Fish oil
Supplement
Placebo or sham
- Placebo
What it measured
Main measures
TNF alpha
3 months
Other measures (1)
IL-1 beta, IL-6, Lipoperoxides, nitric oxide
3 months
Immune response
Who could take part
MS (type not specified) · 18 to 55
Inclusion Criteria: * Patients had clinically definite and magnetic resonance image supported MS * Had at least one relapse in the year before entry into the study * EDSS score of 0-5 * Treated with subcutaneous 250 μg interferon beta-1b (Betaseron, Bayer) Exclusion Criteria: * they were taking another supplement * had progressive forms of MS * had history of severe depression * had history of acute liver or renal dysfunction * had history of tobacco, drug or alcohol abuse * had intolerance, contraindication or allergy to fish oil
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The aim of the present work was to evaluate the efficacy of fish oil supplementation on serum proinflammatory cytokines levels, oxidative stress markers and disease progression in MS.
Papers
Loading reviews and guidelines…
Related trials
- DHAME
Not a drug-phase study · Enrolling by invitation
Still running
- ProChocolate
Not a drug-phase study · Completed
No result found
- Probiotic Intervention for People With Multiple Sclerosis
Not a drug-phase study · Completed
No result found
- VDSS
Not a drug-phase study · Completed
No result found
- Impact of Ketone Bodies and Epigallocatechin Gallate in M…
Phase 2 · Completed
Result in a paper, not read yet
- Role of Vitamin D in Reducing the Relapse Rate in Patient…
Phase 2 · Status unknown
No result found
History
Started
May 2010
Main results due
Dec 2011
Finished
Dec 2012
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error